Sunzen Biotech Bhd (0148) — Capital Reinvestment Ratio
Sunzen Biotech Bhd (0148) has a Capital Reinvestment Ratio of 0.03x as of September 2023, meaning it reinvests 0% of its operating cash flow (RM3.58 Million) in capital expenditures (RM95.00K). Check 0148 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sunzen Biotech Bhd Capital Reinvestment Ratio (2016–2023)
This chart tracks Sunzen Biotech Bhd's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Sunzen Biotech Bhd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Sunzen Biotech Bhd (2016–2023)
Year-by-year Capital Reinvestment Ratio for Sunzen Biotech Bhd from 2016 to 2023. See Sunzen Biotech Bhd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.23x | RM819.39K | RM1.01 Million | ▲ +667.0% |
| 2020 | 0.16x | RM7.20 Million | RM1.16 Million | ▼ -81.1% |
| 2017 | 0.85x | RM4.02 Million | RM3.42 Million | ▼ -96.7% |
| 2016 | 25.91x | RM256.13K | RM6.64 Million | — |